1 |
Jurcau A, Jurcau CM. Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 2023;18:1472-7. [PMID: 36571344 DOI: 10.4103/1673-5374.360289] [Reference Citation Analysis]
|
2 |
Andronie-cioara FL, Ardelean AI, Nistor-cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression. IJMS 2023;24:1869. [DOI: 10.3390/ijms24031869] [Reference Citation Analysis]
|
3 |
Wu J, Möhle L, Brüning T, Eiriz I, Rafehi M, Stefan K, Stefan SM, Pahnke J. A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. Int J Mol Sci 2022;23. [PMID: 36499090 DOI: 10.3390/ijms232314763] [Reference Citation Analysis]
|
4 |
Siafaka PI, Okur ME, Erim PD, Çağlar EŞ, Özgenç E, Gündoğdu E, Köprülü REP, Karantas ID, Üstündağ Okur N. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics 2022;14:2425. [DOI: 10.3390/pharmaceutics14112425] [Reference Citation Analysis]
|